XTLB
XTL Biopharmaceuticals
XTLB
XTLB
4 hedge funds and large institutions have $232K invested in XTL Biopharmaceuticals in 2020 Q4 according to their latest regulatory filings, with 1 funds opening new positions, 1 increasing their positions, reducing their positions, and 1 closing their positions.
Holders
4
Holders Change
–
Holders Change %
0%
% of All Funds
0.07%
Holding in Top 10
–
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
–
New
1
Increased
1
Reduced
–
Closed
1
Calls
–
Puts
–
Net Calls
–
Net Calls Change
–
Top Buyers
| 1 |
1
Renaissance Technologies
New York
|
$59K |
| 2 |
2
Morgan Stanley
New York
|
$172K |
Top Sellers
| 1 |
1
UBS Group
Zurich,
Switzerland
|
$0 |
| Name | Market Value | Shares |
Shares Change |
Shares Change % |
|
|---|---|---|---|---|---|
|
1
Morgan Stanley
New York
| $172K | 56,823 | +9,392 | +20% |
|
|
2
Renaissance Technologies
New York
| $59K | 19,531 | +19,531 | New |
|
|
NI
3
Noked Israel
Ramat Hasharon,
Israel
| $603 | 198,888 | – | – |
|
|
NC
4
Noked Capital
Tel Aviv,
Israel
| $603 | 198,888 | – | – |
|
|
5
UBS Group
Zurich,
Switzerland
| – | – | -1,036 | Closed |
|
|
CFGS
6
Concourse Financial Group Securities
Birmingham,
Alabama
| – | – | – | – |
|